Fidia in
Joint Care
Fidia Pharma USA Inc., a wholly owned subsidiary of Fidia Farmaceutici S.p.A. (Italy), offers a comprehensive range of hyaluronic acid (HA) viscosupplement brands designed to address both physician preferences for injection frequency and patient accessibility in managing osteoarthritis (OA) knee pain.
For more than 15 years, we have remained dedicated to helping relieve the pain caused by knee osteoarthritis.
OUR INNOVATION
OUR HYALURONIC ACID
Since 1946, our parent company has been dedicated to research and development, striving to provide integrated, effective, and safe products and services for healthcare professionals, patients, and global partners, all with an optimal balance of quality and value.
Every day, we focus on maintaining the highest standards of quality and technological excellence, driven by our people, our ideas, and our core values.
Our hyaluronic acid fractions have varying molecular weights, each possessing distinct physicochemical properties and offering a broad range of medical applications.
OUR HA PRODUCT PORTFOLIO
OUR PRP PRODUCT PORTFOLIO
The RICHPLAT ORTHO® Platelet Rich Plasma System is designed to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of peripheral blood at the patient’s point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.